Publikationen von Silvia Querings
Alle Typen
Zeitschriftenartikel (7)
2013
Zeitschriftenartikel
8 (1), e53081 (2013)
Prognostic impact of [18F]fluorothymidine and [18F]fluoro-D-glucose baseline uptakes in patients with lung cancer treated first-line with Erlotinib. PLoS ONE
Zeitschriftenartikel
5 (209), 209ra153 (2013)
A genomics-based classification of human lung tumors. Science Translational Medicine 2011
Zeitschriftenartikel
1 (1), S. 78 - 89 (2011)
Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer. Cancer Discovery
Zeitschriftenartikel
6 (5), S. e19601 - e19601 (2011)
Benchmarking of mutation diagnostics in clinical lung cancer specimens. PLoS ONE
Zeitschriftenartikel
29 (13), S. 1701 - 1708 (2011)
Early prediction of nonprogression in advanced non-small-cell lung cancer treated with erlotinib by using [18F] fluorodeoxyglucose and [ 18F] fluorothymidine positron emission tomography. Journal of Clinical Oncology 2010
Zeitschriftenartikel
5 (3), S. 407 - 409 (2010)
Osteoblastic response in patients with non-small cell lung cancer with activating EGFR mutations and bone metastases during treatment with EGFR kinase inhibitors. Journal of Thoracic Oncology
Zeitschriftenartikel
2 (62), S. 62ra93 - 62ra93 (2010)
Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer. Science Translational Medicine